Could Serological Markers of the Dengue Viral Disease Predict the Outcomes in Pregnant South Asian Population?

Authors : Dr. Harshita Guruprasad; Dr. Lakshmi Rachakonda; Dr. Shubhangi Mande

Volume/Issue : Volume 5 - 2020, Issue 9 - September

Google Scholar :

Scribd :

DOI : 10.38124/IJISRT20SEP584

A recent rise in the incidence of a vector borne viral disease, Dengue Disease, in South Asian countries has also shown an impact on the pregnant population in these regions. There are four known Dengue virus serotypes, the predominant ones being DENV- 2 and DENV-3, when present during pregnancy could be associated with complications like preterm birth, maternal mortality and morbidity and adverse neonatal outcomes.[1]. We aimed to study the outcomes in the pregnant patients that presented to our institution with the Dengue disease.  Methods: A 6-month (1/9/2019 – 29/2/2020) study was undertaken during the months of high prevalence of the Dengue disease in our region. Clinical, laboratory, maternal and foetal outcomes were studied among serologically positive dengue mothers treated at MGM Hospital, Aurangabad. A total of 25 patients were found to have Dengue disease during the study period. NS1Ag and IGM serological analysis results were used to achieve diagnosis and early management. 7 patients had symptomatic thrombocytopenia and needed platelet transfusions. Majority of our patients had favourable outcomes. 3 mothers died succumbing to the multiorgan failure. Favourable maternal and foetal outcomes could be achieved with early diagnosis of suspected Dengue disease with both NS1Ag and IGM serological analysis.

Keywords : Dengue in Pregnancy, Outcomes of Dengue Fever, Serological Markers in Dengue.


Paper Submission Last Date
31 - May - 2022

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.